David Tepper - Appaloosa Management
Holding/activity history for Boston Scientific (BSX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2020 Q4 | 0 | 0 | Sell 100.00% | 0.53 | |
| 2020 Q3 | 787,500 | 0.53 | Reduce 17.11% | 0.11 | $38.21 |
| 2020 Q2 | 950,000 | 0.58 | Add 726.09% | 0.51 | $35.11 |
| 2020 Q1 | 115,000 | 0.11 | Buy | 0.11 | $32.63 |
| 2018 Q4 | 0 | 0 | Sell 100.00% | 0.59 | |
| 2018 Q3 | 853,875 | 0.59 | Reduce 66.23% | 1.16 | $38.50 |
| 2018 Q2 | 2,528,138 | 0.96 | Reduce 35.35% | 0.53 | $32.70 |
| 2018 Q1 | 3,910,738 | 1.15 | Reduce 18.23% | 0.26 | $27.32 |
| 2017 Q4 | 4,782,683 | 1.36 | Add 27.44% | 0.29 | $24.79 |
| 2017 Q3 | 3,752,866 | 1.64 | Add 65.70% | 0.65 | $29.17 |
| 2017 Q2 | 2,264,900 | 0.99 | Reduce 32.19% | 0.47 | $27.72 |
| 2017 Q1 | 3,340,000 | 1.46 | Add 507.27% | 1.22 | $24.87 |
| 2016 Q4 | 550,000 | 0.22 | Buy | 0.22 | $21.63 |
| 2012 Q1 | 0 | 0 | Sell 100.00% | 7.06 | |
| 2011 Q4 | 7,797,503 | 7.06 | Buy | 7.06 | $5.34 |